The low plasma concentrations of pentoxifylline, together with the gastrointestinal side effects associated with the use of PDE inhibitors, has limited further investigation of several PDE inhibitors for use in the context of HIV-1 infection. This evidence concerns the gene ALDH7A1 and HIV-1 infection.